Advanced flow cytometry for stem cell research
Full Spectrum Flow Cytometer
This study is all about getting a new, advanced machine that helps scientists better understand stem cells and how they can improve treatments for patients, so everyone can benefit from new discoveries in regenerative medicine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11102913 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of flow cytometry at the Sanford Consortium for Regenerative Medicine by acquiring a state-of-the-art full-spectrum flow cytometer. This advanced equipment will allow researchers to analyze a greater number of parameters simultaneously, which is crucial for studying complex biological systems, particularly in stem cell research. By providing access to high-throughput screening and improved analytical capabilities, the facility aims to foster collaborative research among multiple institutions. Patients may benefit indirectly through advancements in stem cell therapies and regenerative medicine resulting from this enhanced research capacity.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research are individuals with conditions that could be treated or improved through stem cell therapies.
Not a fit: Patients with conditions unrelated to stem cell therapies or those not involved in ongoing research collaborations may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant advancements in stem cell therapies and regenerative medicine, potentially improving treatment options for various conditions.
How similar studies have performed: Other research initiatives utilizing advanced flow cytometry have shown promise in enhancing our understanding of stem cell biology and improving therapeutic applications.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Willert, Karl H — University of California, San Diego
- Study coordinator: Willert, Karl H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.